Work

Abstract A50: Circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast cancer patients in the I-SPY 2 TRIAL

Year: 2020

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.liqbiop20-a50

Authors: Mark Jesus M. Magbanua, Wen Li, Denise M. Wolf, Christina Yau, Gillian L. Hirst, Lamorna Brown-Swigart, A. Jo Chien, Amy L. Delson, Jessica Gibbs, Alexey Aleshin, Bernhard Zimmerman, Laura Esserman, Nola Hylton, Laura van 't Veer

Institutions: University of California, San Francisco, Natera (United States)

Language: English

Topic: MRI in cancer diagnosis

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3034101282

Cites:

Cited by: 3

Related to: 10